FDA STANDARD OF +/-20% ADEQUATE TO ASSURE BIOEQUIVALENCE OF GENERICS, TASK FORCE MAINTAINS; +/-10% CRITERIA HAS "SOME MERIT" AS EXTRA ASSURANCE